Insider · CIK 0001711352
Stanford L Peng
Files at ALPN (ALPINE IMMUNE SCIENCES, INC.). First filing -, latest -.
In brief
Stanford L Peng files SEC Form 4 as officer at ALPN (ALPINE IMMUNE SCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stanford L Peng has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Common Stock | -296,163 | - | - | 48,000 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Common Stock | -48,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -42,407 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -236,623 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -71,874 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -50,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -81,088 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -142,975 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -215,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -150,000 | - | - | 0 | May 20, 2024 |
| May 20, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | DDisposition to issuer Stock Option (Right to buy)derivative | -120,000 | - | - | 0 | May 20, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +7,025 | $13.20 | $93k | 79,396 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +3,126 | $6.51 | $20k | 82,522 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +37,267 | $0.65 | $24k | 119,789 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +161,492 | $0.65 | $105k | 281,281 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +22,593 | $11.31 | $256k | 303,874 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +26,912 | $3.23 | $87k | 330,786 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Common Stock | +13,377 | $6.33 | $85k | 344,163 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -7,025 | $0.00 | $0 | 142,975 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -3,126 | $0.00 | $0 | 71,874 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -37,267 | $0.00 | $0 | 0 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -161,492 | $0.00 | $0 | 0 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -22,593 | $0.00 | $0 | 42,407 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -26,912 | $0.00 | $0 | 81,088 | May 10, 2024 |
| May 8, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | MOption exercise Stock Option (Right to buy)derivative | -13,377 | $0.00 | $0 | 236,623 | May 10, 2024 |
| Jan 4, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | AGrant or award Common Stock | +48,000 | $0.00 | $0 | 72,371 | Jan 5, 2024 |
| Jan 4, 2024 | ALPN ALPINE IMMUNE SCIENCES, INC. | AGrant or award Stock Option (Right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jan 5, 2024 |
| Jan 4, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | AGrant or award Stock Option (Right to buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Jan 5, 2023 |
Questions about Stanford L Peng
Answered from the filings on this page, as of the latest one.
Is Stanford L Peng buying or selling?
Stanford L Peng has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stanford L Peng's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stanford L Peng has 0.
Where does Stanford L Peng file Form 4?
Stanford L Peng has filed Form 4 at ALPN (ALPINE IMMUNE SCIENCES, INC.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.